(Q33952282)

30 July 2017

Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial (English)

1 reference

30 July 2017

0 references

Sander Koning

1

1 reference

30 July 2017

Lisette W A van Suijlekom-Smit

2

1 reference

30 July 2017

Jan L Nouwen

3

1 reference

30 July 2017

Cees M Verduin

4

1 reference

30 July 2017

Roos M D Bernsen

5

1 reference

30 July 2017

Arnold P Oranje

6

1 reference

30 July 2017

Siep Thomas

7

1 reference

30 July 2017

Johannes C van der Wouden

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

30 July 2017

1 reference

30 July 2017

324

1 reference

30 July 2017

7331

1 reference

30 July 2017

203-206

1 reference

Fucidin: a new orally active antibiotic

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Resistance to antibiotics used in dermatological practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Interpretive criteria for testing susceptibility of staphylococci to mupirocin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Treatment of impetigo: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Prescribing antibiotics for impetigo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Comparison of mupirocin and erythromycin in the treatment of impetigo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64791

Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995

5 July 2018

1 reference

12 December 2020

Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo

1 reference

12 December 2020

Experimental infection of the skin in the hamster simulating human impetigo. II. Assessment of various therapeutic regimens

1 reference

12 December 2020

The influence of hexachlorophene scrubs on the response to placebo or penicillin therapy in impetigo

1 reference

12 December 2020

A three-year study of impetigo in Sydney

1 reference

12 December 2020

A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.324.7331.203

1 reference

30 July 2017

1 reference

30 July 2017

1 reference